1. COMIRNATY and COMIRNATY Bivalent have same colour vial cap

   News item 15 October 2022 Pages: 1 - 1

2. Infant cough medicines in Gambia contaminated

   News item 15 October 2022 Pages: 2 - 2

3. Metformin may increase risk of vitamin B12 deficiency

   News item 15 October 2022 Pages: 3 - 3

4. Minimising brolucizumab-related retinal vasculitis, retinal vein occlusion

   News item 15 October 2022 Pages: 4 - 4

5. Nirmatrelvir/ritonavir-related anaphylaxis

   News item 15 October 2022 Pages: 5 - 5

6. One lot of AuroMedics acyclovir recalled in US due to particulate

   News item 15 October 2022 Pages: 6 - 6

7. ADRs related to drug shortages increasingly common: a study from France

   Clinical study 15 October 2022 Pages: 7 - 7

8. Early antibacterial use increases risk of death in very preterm neonates

   Clinical study 15 October 2022 Pages: 8 - 8

9. Lorlatinib-related neurocognitive effects

   Clinical study 15 October 2022 Pages: 9 - 9

10. Most FAERS safety signals lead to FDA regulatory action

    Clinical study 15 October 2022 Pages: 10 - 10

11. mRNA COVID-19 vaccine safety in recipients aged 12 to 64 years

    Clinical study 15 October 2022 Pages: 11 - 11

12. New daptomycin ADR signals identified

    Clinical study 15 October 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 15 October 2022 Pages: 13 - 13

14. Ad26.cov2-s

    Case report 15 October 2022 Pages: 14 - 14

15. Ad26.COV2-S

    Case report 15 October 2022 Pages: 15 - 15

16. Adalimumab/duloxetine/ustekinumab

    Case report 15 October 2022 Pages: 16 - 16

17. Adalimumab/tildrakizumab

    Case report 15 October 2022 Pages: 17 - 17

18. Aflibercept/brolucizumab/ranibizumab

    Case report 15 October 2022 Pages: 18 - 18

19. Aflibercept/mycophenolate-mofetil/prednisone

    Case report 15 October 2022 Pages: 19 - 19

20. Albendazole/metronidazole

    Case report 15 October 2022 Pages: 20 - 20

21. Albumin-human/AZD-1222/diuretics

    Case report 15 October 2022 Pages: 21 - 21

22. Alemtuzumab/mogamulizumab/pembrolizumab

    Case report 15 October 2022 Pages: 22 - 22

23. Alprostadil

    Case report 15 October 2022 Pages: 23 - 23

24. Alprostadil

    Case report 15 October 2022 Pages: 24 - 24

25. Amino acids mix/90Y-dotatate/lutetium-(177Lu)-oxodotreotide

    Case report 15 October 2022 Pages: 25 - 25

26. Amiodarone

    Case report 15 October 2022 Pages: 26 - 26

27. Amiodarone

    Case report 15 October 2022 Pages: 27 - 27

28. Amiodarone/diltiazem/pitavastatin interaction

    Case report 15 October 2022 Pages: 28 - 28

29. Amiodarone/potassium

    Case report 15 October 2022 Pages: 29 - 29

30. Amisulpride/risperidone

    Case report 15 October 2022 Pages: 30 - 30

31. Amoxicillin/benzylpenicillin

    Case report 15 October 2022 Pages: 31 - 31

32. Amoxicillin/clavulanic-acid/denosumab

    Case report 15 October 2022 Pages: 32 - 32

33. Amrubicin

    Case report 15 October 2022 Pages: 33 - 33

34. Angelicae-radix/astragalus-propinquus/atractylodes-lancea/citrus-reticulata/cinnamon/ginseng/paeonia/polygala-senega/radix-glycyrrhizae/rehmannia/schisandra/wolfiporia-extensa/donepezil

    Case report 15 October 2022 Pages: 34 - 34

35. Anti-inflammatories

    Case report 15 October 2022 Pages: 35 - 35

36. Antibacterials

    Case report 15 October 2022 Pages: 36 - 36

37. Antibacterials/Antituberculars

    Case report 15 October 2022 Pages: 37 - 37

38. Antibacterials/immunosuppressants

    Case report 15 October 2022 Pages: 38 - 38

39. Antibacterials/tocilizumab

    Case report 15 October 2022 Pages: 39 - 39

40. Antidepressants/antipsychotics/antiretrovirals

    Case report 15 October 2022 Pages: 40 - 40

41. Antiepileptic drugs

    Case report 15 October 2022 Pages: 41 - 41

42. Antiepileptic drugs

    Case report 15 October 2022 Pages: 42 - 42

43. Antiepileptic-drugs

    Case report 15 October 2022 Pages: 43 - 43

44. Antifungal drugs/glucocorticoids

    Case report 15 October 2022 Pages: 44 - 44

45. Antihistamines/antipsoriatics

    Case report 15 October 2022 Pages: 45 - 45

46. Antihyperglycaemics

    Case report 15 October 2022 Pages: 46 - 46

47. Antihyperglycaemics

    Case report 15 October 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 15 October 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 15 October 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 15 October 2022 Pages: 50 - 50